about
Variability of the nerve supply patterns of the human posterior cricoarytenoid muscle.Comparison of the Radiation Therapy Oncology Group recursive partitioning classification and Union Internationale Contre le Cancer TNM classification for patients with head and neck carcinoma.Variability in nerve patterns of the adductor muscle group supplied by the recurrent laryngeal nerve.External validation of a risk group defined by recursive partitioning analysis in patients with head and neck carcinoma treated with surgery and postoperative radiotherapy.[Organ preservation in laryngeal and hypopharyngeal cancer].An anatomical study of anastomoses between the laryngeal nerves.Parotid incidentaloma identified by positron emission/computed tomography: when to consider diagnoses other than warthin tumor.HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients.Expression of IL-1α correlates with distant metastasis in patients with head and neck squamous cell carcinoma.Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.Lymphadenopathy caused by Mycobacterium colombiense.High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma.Salvage surgery after locoregional failure in head and neck carcinoma patients treated with chemoradiotherapy.European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer.Oropharyngeal and laryngeal sensory innervation in the pathophysiology of swallowing disorders and sensory stimulation treatments.How Phenotype Guides Management of the Most Common Malignant Salivary Neoplasms of the Larynx?Prostacyclin-synthase expression in head and neck carcinoma patients and its prognostic value in the response to radiotherapy.How phenotype guides management of non-conventional squamous cell carcinomas of the larynx?Surgical options in benign parotid tumors: a proposal for classification.Classification of parotidectomies: a proposal of the European Salivary Gland Society.External validation of sTWEAK as a prognostic noninvasive biomarker for head and neck squamous cell carcinoma.Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study.CKMT1 and NCOA1 expression as a predictor of clinical outcome in patients with advanced-stage head and neck squamous cell carcinoma.A Novel Role For Nanog As An Early Cancer Risk Marker In Patients With Laryngeal Precancerous LesionsInteraction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE2.Gene expression signatures and molecular markers associated with clinical outcome in locally advanced head and neck carcinoma.Recurrent laryngeal squamous cell carcinoma: rTNM versus composite laryngeal recurrence staging system. Proposal for a modification of the CLRSS to improve patient classification.Risk of third and fourth tumors in patients with head and neck cancer.Elective treatment of the neck for second primary tumors of the head and neck.[Prevalence of tobacco and alcohol use following treatment in patients with head and neck squamous carcinoma: a cross-sectional study]The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis.Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced laryngeal carcinoma.Metachronous second primary tumours in the aerodigestive tract in patients with early stage head and neck squamous cell carcinomas.The effect of waiting time on local control and survival in head and neck carcinoma patients treated with radiotherapy.Second, third, and fourth head and neck tumors. A progressive decrease in survival.Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case-control study.Prostaglandin E(2) pathway in head and neck squamous cell carcinoma.Mutation analysis of the SDHD gene in four kindreds with familial paraganglioma: description of one novel germline mutation.Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer.Prognostic value of CD45 transcriptional expression in head and neck cancer.
P50
Q30910222-25D1AEAE-0DB3-4FBC-AC68-FB8DB9554CE4Q31143679-8F1BB21A-E538-4BCA-B037-77FB35454037Q31146054-C829502C-5B9B-4C81-9A59-07BC6E2B6F46Q33280896-84BD64E3-B7F8-419E-B22A-5BF76E864B97Q33310507-CD2EF771-96C0-49D7-8E4D-3326C4174D91Q33864891-6BEB27BB-5BEE-4F4E-9A78-66E196F8CC0CQ35440916-33C4C89C-F18D-44CA-A167-0C3CEEC2EEA2Q35908027-25B3438F-B6F0-4277-B5CA-CD940AE5064DQ36545754-63C5EA5F-80F3-4BCE-B133-D7546202FE20Q36557197-AFB2C29E-6437-4686-98DB-F35320408B10Q36672992-C72A59C9-09FC-4F3A-8FD2-20811D4437EDQ37481225-65CA7E05-3026-4976-85A8-0A940E795005Q37780973-FC173B3B-929A-48B0-B1E5-07CCFFA2BD07Q38194464-5A2C6166-961F-42A2-8FB4-5FCD722E784CQ38904361-45D9FB3A-7FEC-41A1-AB2B-A6E4137C0893Q38948765-097F7D39-F9E9-4974-98E7-24ABF389EAC0Q38953336-20505157-676A-4423-ACFE-E47286CDEEBCQ39212364-265399CD-EF4E-47EB-AFF3-24147C4E1781Q39389879-3F620487-96C8-4FD7-8286-42785E32E9B8Q40009565-9F382630-BBCF-4C28-AD04-CC02A4946528Q40202959-CBEC5D70-4ED6-4B0C-B244-05CE9F018E1BQ40277050-68684AAC-151D-4334-AC2C-FE8301B5CA8CQ40375971-3798136B-3899-4958-8960-51833D3FCF58Q41319418-81AD2A61-0F4F-4B98-8266-7D6955A981D1Q41875453-540EB37D-F69C-4054-8678-08DCDDCDF2BEQ43627457-E14DF89A-B068-4940-A6A0-129C598CB196Q43857944-55F3170C-6E46-4A40-BBFF-1C11CA19CBF6Q44030794-0876539A-0E20-4429-BB9C-20F3CD29FD06Q44136533-EC410512-9F6C-465F-BA9B-7A74D9D3876CQ44377616-70A44984-B3BC-4EA2-AC21-37DD662E6CE9Q44706685-B062A3E1-E51F-4FB1-9313-AD4F4B2A2597Q44777945-7FA144CC-C6F1-4477-B976-3297D7E94C67Q44825150-7B65D95F-5654-490E-A684-E0B10DA7E2D9Q44955249-E6F57293-05FA-4533-9F18-D1F94C36385AQ45768534-72E1A713-543F-447F-B21B-52B79F997F63Q46208052-0B72CB42-4AD7-4E07-9349-E1EBD8B7A965Q46472384-35CA3E9A-94E1-4558-9CFF-5A8C330D161AQ46500033-EEFE4D28-52E3-4C2C-B6DB-03B6BFC36BD5Q46546357-750F9BF6-79FC-4D90-88D4-BC15AFBE9D4FQ47361788-3F057F40-E974-4F65-A854-88B4BEFAAAB5
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Miquel Quer
@ast
Miquel Quer
@en
Miquel Quer
@es
Miquel Quer
@it
Miquel Quer
@nl
Miquel Quer
@sl
type
label
Miquel Quer
@ast
Miquel Quer
@en
Miquel Quer
@es
Miquel Quer
@it
Miquel Quer
@nl
Miquel Quer
@sl
prefLabel
Miquel Quer
@ast
Miquel Quer
@en
Miquel Quer
@es
Miquel Quer
@it
Miquel Quer
@nl
Miquel Quer
@sl
P214
P950
P106
P1153
7003550744
P1580
P21
P214
P31
P496
0000-0003-2563-6729
P734
P735
P7859
viaf-87738113